304 related articles for article (PubMed ID: 24762312)
1. Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.
Mathew A; Townsley E; Ennis FA
Future Microbiol; 2014; 9(3):411-25. PubMed ID: 24762312
[TBL] [Abstract][Full Text] [Related]
2. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
[TBL] [Abstract][Full Text] [Related]
3. Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.
Rivino L; Kumaran EA; Jovanovic V; Nadua K; Teo EW; Pang SW; Teo GH; Gan VC; Lye DC; Leo YS; Hanson BJ; Smith KG; Bertoletti A; Kemeny DM; MacAry PA
J Virol; 2013 Mar; 87(5):2693-706. PubMed ID: 23255803
[TBL] [Abstract][Full Text] [Related]
4. A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.
Roth C; Cantaert T; Colas C; Prot M; Casadémont I; Levillayer L; Thalmensi J; Langlade-Demoyen P; Gerke C; Bahl K; Ciaramella G; Simon-Loriere E; Sakuntabhai A
Front Immunol; 2019; 10():1424. PubMed ID: 31293584
[TBL] [Abstract][Full Text] [Related]
5. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
Elong Ngono A; Shresta S
Front Immunol; 2019; 10():1316. PubMed ID: 31244855
[TBL] [Abstract][Full Text] [Related]
6. Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes.
Piazza P; Campbell D; Marques E; Hildebrand WH; Buchli R; Mailliard R; Rinaldo CR
Clin Exp Immunol; 2014 Sep; 177(3):696-702. PubMed ID: 24816171
[TBL] [Abstract][Full Text] [Related]
7. Immunoinformatics and molecular docking studies reveal potential epitope-based peptide vaccine against DENV-NS3 protein.
Tahir RA; Wu H; Rizwan MA; Jafar TH; Saleem S; Sehgal SA
J Theor Biol; 2018 Dec; 459():162-170. PubMed ID: 30291844
[TBL] [Abstract][Full Text] [Related]
8. T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.
Pinto PBA; Assis ML; Vallochi AL; Pacheco AR; Lima LM; Quaresma KRL; Pereira BAS; Costa SM; Alves AMB
Front Immunol; 2019; 10():1522. PubMed ID: 31333657
[TBL] [Abstract][Full Text] [Related]
9. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
Liang H; Lee M; Jin X
Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
[TBL] [Abstract][Full Text] [Related]
10. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
Front Immunol; 2018; 9():2225. PubMed ID: 30327651
[TBL] [Abstract][Full Text] [Related]
11. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.
Weiskopf D; Angelo MA; Sidney J; Peters B; Shresta S; Sette A
J Virol; 2014 Oct; 88(19):11383-94. PubMed ID: 25056881
[TBL] [Abstract][Full Text] [Related]
12. Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques.
Mladinich KM; Piaskowski SM; Rudersdorf R; Eernisse CM; Weisgrau KL; Martins MA; Furlott JR; Partidos CD; Brewoo JN; Osorio JE; Wilson NA; Rakasz EG; Watkins DI
Immunogenetics; 2012 Feb; 64(2):111-21. PubMed ID: 21881953
[TBL] [Abstract][Full Text] [Related]
13. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
[TBL] [Abstract][Full Text] [Related]
14. Immunodomination of Serotype-Specific CD4+ T-Cell Epitopes Contributed to the Biased Immune Responses Induced by a Tetravalent Measles-Vectored Dengue Vaccine.
Lin TH; Chen HW; Hsiao YJ; Yan JY; Chiang CY; Chen MY; Hu HM; Wu SH; Pan CH
Front Immunol; 2020; 11():546. PubMed ID: 32300346
[TBL] [Abstract][Full Text] [Related]
15. T cell immunity to dengue virus and implications for vaccine design.
Rivino L
Expert Rev Vaccines; 2016; 15(4):443-53. PubMed ID: 26560171
[TBL] [Abstract][Full Text] [Related]
16. Mast cell-macrophage dynamics in modulation of dengue virus infection in skin.
Chu YT; Wan SW; Anderson R; Lin YS
Immunology; 2015 Sep; 146(1):163-72. PubMed ID: 26059780
[TBL] [Abstract][Full Text] [Related]
17. Human CD4
Angelo MA; Grifoni A; O'Rourke PH; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974563
[TBL] [Abstract][Full Text] [Related]
18. Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infection.
Jeewandara C; Adikari TN; Gomes L; Fernando S; Fernando RH; Perera MK; Ariyaratne D; Kamaladasa A; Salimi M; Prathapan S; Ogg GS; Malavige GN
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003673. PubMed ID: 25875020
[TBL] [Abstract][Full Text] [Related]
19. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.
Shukla R; Beesetti H; Brown JA; Ahuja R; Ramasamy V; Shanmugam RK; Poddar A; Batra G; Krammer F; Lim JK; Kale S; Lal AA; Swaminathan S; Khanna N
EBioMedicine; 2020 Oct; 60():102991. PubMed ID: 32949997
[TBL] [Abstract][Full Text] [Related]
20. T-cells producing multiple combinations of IFNγ, TNF and IL10 are associated with mild forms of dengue infection.
Gonçalves Pereira MH; Figueiredo MM; Queiroz CP; Magalhães TVB; Mafra A; Diniz LMO; da Costa ÚL; Gollob KJ; Antonelli LRDV; Santiago HDC
Immunology; 2020 May; 160(1):90-102. PubMed ID: 32128816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
